BioAxone Therapeutic Inc. Announces A Second-Round Investment Of $12.15 Million
10/19/2005 5:09:54 PM
MONTREAL, May 19 /CNW Telbec/ - BioAxone Therapeutic Inc., a Montreal-
based neuroscience company, is pleased to announce the recent closing of a
second-round investment of $12.15 M. Four major venture capital companies,
namely T2C2/Bio2000, Solidarity Fund QFL, Investissement Desjardins and
Lothian Partners 27 SARL, made the investment.
comments powered by